malondialdehyde has been researched along with flunarizine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgers, M; De Clerck, F; Vandewiele, R; Ver Donck, L; Verellen, G | 1 |
| De Clerck, F; Loots, W; Somers, Y; Van Gorp, L; Verheyen, A; Wouters, L | 1 |
| Kubo, K; Kumada, Y; Nakamizo, N; Shuto, K; Yoshitake, I | 1 |
| Im, WB; Ito, C; Kunihara, M; Liou, SY; Takagi, H; Takahashi, M; Tsuzuki, K | 1 |
| Bouillot, L; Elimadi, A; Morin, D; Sapena, R; Tillement, JP | 1 |
| Lan, T; Wang, Y; Xian, Y | 1 |
6 other study(ies) available for malondialdehyde and flunarizine
| Article | Year |
|---|---|
Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes.
Topics: Animals; Benzothiazoles; Calcium Channel Blockers; Cell Separation; Cinnarizine; Diltiazem; Flunarizine; Lidoflazine; Lipid Peroxidation; Malondialdehyde; Myocardium; Nicardipine; Oxygen; Piperidines; Rats; Thiazoles; Verapamil | 1990 |
Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Calcium Channel Blockers; Cinnarizine; Cyclooxygenase Inhibitors; Endothelium; Flunarizine; Guinea Pigs; Hemolysis; Male; Malondialdehyde; Mice; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Piperazines; Receptors, Leukotriene; Receptors, Prostaglandin; Risk; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Time Factors | 1985 |
Radical scavenging action of flunarizine in rat brain in vitro.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain; Cinnarizine; Flunarizine; Free Radicals; In Vitro Techniques; Iron; Kinetics; Lipid Peroxides; Male; Malondialdehyde; Mitochondrial Swelling; Oxygen Consumption; Piperazines; Rats; Rats, Inbred Strains | 1984 |
U-92032, a T-type Ca2+ channel blocker and antioxidant, reduces neuronal ischemic injuries.
Topics: Animals; Antioxidants; Brain Ischemia; Calcium Channel Blockers; Flunarizine; Gerbillinae; Hippocampus; Lipid Peroxidation; Long-Term Potentiation; Malondialdehyde; Mice; Neuroblastoma; Neurons; Piperazines; Rats; Tropolone; Tumor Cells, Cultured | 1994 |
Dose-related inversion of cinnarizine and flunarizine effects on mitochondrial permeability transition.
Topics: Animals; Calcium; Cinnarizine; Dose-Response Relationship, Drug; Flunarizine; Histamine H1 Antagonists; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Membrane Potentials; Mitochondria, Liver; Mitochondrial Swelling; NADP; Oxidation-Reduction; Oxidative Stress; Permeability; Rats; Rats, Wistar | 1998 |
[Protective effects of flunarizine and vitamin C on isolated rat heart subjected to ischemia-reperfusion injury].
Topics: Animals; Ascorbic Acid; Calcium; Calcium Channel Blockers; Female; Flunarizine; In Vitro Techniques; L-Lactate Dehydrogenase; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley | 1998 |